Thank you TELUS Spark Science Centre for lighting up green for #WorldKidneyCancerDay! The centre looks stunning in green 💚 #kidneycancer

Merci TELUS Spark Science Centre d’avoir illuminé en vert à l’occasion de la #JournéeMondialeDuCancerDuRein. Le centre est magnifique ! 💚 #cancerdurein

WOW!! That is impressive!! Thank you Telus Spark Science for ‘lighting up in green’ to support the Canadian #kidneycancer community on June 19 #WorldKidneyCancerDay and bringing awareness. 💚 Kidney Cancer Canada Cancer du rein CA IKCC Kidney Cancer

Not sure how to navigate VHL research? We're here to help! Our newest blog post walks you through our new VHL Research Library - how to use it, what you’ll find, and how to make it work for you. 🔗 Read the post here: vhl.org/your-guide-to-…

Thank you FROGS (Friends Of Renal Oncology Group) for taking part in this years IKCC Kidney Cancer #WKCD2025 they joined the global symposium and wore green to raise awareness of #kidneycancer who knew there are so many shades! More about patients groups: actionkidneycancer.org/help-support/p…

It's a great honor and privilege to introduce to you our newest publication titled: mdpi.com/1422-0067/26/1…

Thank you to Ariana Znaor from IARC for recording a video on the incidence, mortality and prevalence of kidney cancer at the international level. youtube.com/watch?v=WHcpoK… #KidneyCancer

Grateful to this amazing team for their consistent and collaborative efforts. Honored to be part of the 🇹🇷Turkish Kidney Cancer Consortium (TKCC). Let’s keep working, growing, and publishing together! 🧠🧬 OncoAlert Ankara Üniversitesi Oncology Brothers KidneyCAN IKCC Kidney Cancer Kidney Cancer

VHL-associated RCC is not indolent. We need better than surveillance. European Urology European Association of Urology (EAU) Amer. Urol. Assn. ESMO - Eur. Oncology ASCO VHL Alliance KidneyCAN IKCC Kidney Cancer Kidney Cancer National Cancer Institute Mark Ball, MD, FACS OncoAlert Oncology Brothers doi.org/10.1016/j.euru…

🎊 Abstract Submissions for #IKCSNA25 are Open! 🎊 Join the KCA on Nov 13-15 in Denver, CO for the 2025 IKCS: North America. Gather with top #kidneycancer experts to discuss and advance the field! But first! Submit your abstracts and register: bit.ly/44tZSiH

🎉 We're so excited to have Kimryn Rathmell The James join us in conversation during the KCA's Women in RCC summer webinar next month! 👉Register today:bit.ly/3Gf9wgV

Did you miss the Global Patient & Carer Symposium on #WorldKidneyCancerDay? You can watch the recording on YouTube! youtube.com/watch?v=-1LXYV… #WKCD25

This is a FREE event, open to anyone who would like to join us! us02web.zoom.us/meeting/regist…

Brilliant mind, driving historic breakthroughs through top-tier collaborations and visionary research. The future of kidney cancer is being rewritten. Thanks for this exciting post!! #RCC Kidney Cancer IKCC Kidney Cancer

Great job Serhat, and huge congratulations to the whole TKCC team! It’s a joy to see this meaningful work come to life! OncoAlert Emre Yekedüz KidneyCAN Kidney Cancer IKCC Kidney Cancer

In a European study of second-line treatments for metastatic #kidneycancer that does not respond to first-line treatment, or becomes resistant to first-line treatment, cabozantinib was the most commonly used treatment and results in good patient outcomes. actionkidneycancer.org/cabozantinib-m…

We’re thrilled to launch the VHL Research Library! Built for patients, families, and caregivers, this free online resource brings the latest VHL research into one searchable, easy-to-use place. No science degree required. 📚 Start exploring today: vhl.org/your-guide-to-…

We’re looking forward to #KCRS2025!

We now have more than 1,000 followers on LinkedIn! If you haven’t yet, you can follow us at linkedin.com/company/ikcc/ #KidneyCancer

Very important, clinically relevant question! Why does ICI re-challenge show limited benefit in metastatic kidney cancer? Is it the tumor microenvironment? Immune exhaustion? Or our sequencing strategies? OncoAlert KidneyCAN IKCC Kidney Cancer Ankara Üniversitesi Tıp Fakültesi